Category C Potential Bioterrorism Agents and Emerging Pathogens
Overview
Affiliations
Curran E, Devine M, Hartley C, Huang Y, Conrady C, Debiec M Front Med (Lausanne). 2024; 10:1349571.
PMID: 38293299 PMC: 10824978. DOI: 10.3389/fmed.2023.1349571.
Biselli R, Nisini R, Lista F, Autore A, Lastilla M, De Lorenzo G Biomedicines. 2022; 10(8).
PMID: 36009598 PMC: 9405556. DOI: 10.3390/biomedicines10082050.
The Input of Structural Vaccinology in the Search for Vaccines against Bunyaviruses.
Serris A Viruses. 2021; 13(9).
PMID: 34578349 PMC: 8473429. DOI: 10.3390/v13091766.
Biowarfare, bioterrorism and biocrime: A historical overview on microbial harmful applications.
Oliveira M, Mason-Buck G, Ballard D, Branicki W, Amorim A Forensic Sci Int. 2020; 314:110366.
PMID: 32683271 PMC: 7305902. DOI: 10.1016/j.forsciint.2020.110366.
Hendra and nipah infection: pathology, models and potential therapies.
Vigant F, Lee B Infect Disord Drug Targets. 2011; 11(3):315-36.
PMID: 21488828 PMC: 3253017. DOI: 10.2174/187152611795768097.